{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:42:24Z","timestamp":1794904944068,"version":"4.9.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"name":"seattle children's hospital center for clinical and translational research"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Fontan-associated liver disease is a unique form of congestive hepatopathy occurring after Fontan palliation of single functional ventricle congenital heart disease. Although congestive hepatic fibrosis post-Fontan has been scored with various histologic systems, none have been validated in this population. The Congestive Hepatic Fibrosis Score (CHFS) was developed to assess liver disease in congestive hepatopathy secondary to chronic right heart failure and is a promising tool for staging congestive hepatic fibrosis post-Fontan. We sought to validate the CHFS in this setting and to examine clinical, laboratory, and hemodynamic parameters impacting the development of Fontan-associated liver disease. Three pathologists reviewed liver biopsies from 42 pediatric and adult post-Fontan patients, with review of clinical, laboratory, and hemodynamic parameters. CHFS and METAVIR fibrosis scores divided biopsies into identical clusters of low stage (stages 0, 1, and 2) and high stage (stages 3 and 4) fibrosis. Interobserver variability for both scores was moderate. Patients with high-stage fibrosis had significantly longer mean time since Fontan. Female patients were more likely to have high-stage fibrosis. Hemodynamic variables had no significant differences between the groups. We conclude that CHFS is a valid scoring method in pediatric and adult patients post-Fontan. Time since Fontan is the best predictor of severe hepatic fibrosis, but much interpatient variation is not explained by any of the identified clinical, laboratory, or hemodynamic parameters. Liver biopsy, therefore, remains the best means of assessing liver fibrosis in post-Fontan patients.<\/jats:p>","DOI":"10.1097\/pas.0000000000002418","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T06:00:07Z","timestamp":1748239207000},"page":"942-947","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Validation of Congestive Hepatic Fibrosis Score in Pediatric and Adult Fontan-Associated Liver Disease"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-2139","authenticated-orcid":false,"given":"Robyn C.","family":"Reed","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Files","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Vermont Medical Center, Burlington, VT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humera","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn K.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mau","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seattle Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"R1-20250815","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1002\/ehf2.13294","article-title":"Reaching consensus for unified medical language in Fontan care","volume":"8","author":"Alsaied","year":"2021","journal-title":"ESC Hear Fail"},{"key":"R2-20250815","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jjcc.2019.02.016","article-title":"Fontan-associated liver disease: a review","volume":"74","author":"Gordon-Walker","year":"2019","journal-title":"J Cardiol"},{"key":"R3-20250815","doi-asserted-by":"crossref","first-page":"1100514","DOI":"10.3389\/fped.2023.1100514","article-title":"Fontan-associated liver disease: diagnosis, surveillance, and management","volume":"11","author":"de Lange","year":"2023","journal-title":"Front Pediatr"},{"key":"R4-20250815","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jtcvs.2011.08.038","article-title":"Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: An autopsy study","volume":"143","author":"Schwartz","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R5-20250815","first-page":"217","article-title":"Fontan-associated liver disease: evidence for early surveillance of liver health in pediatric Fontan patients","volume":"35","author":"Rathgeber","year":"2019","journal-title":"Can J Cardiol"},{"key":"R6-20250815","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/PG9.0000000000000207","article-title":"Care pattern for Fontan-associated liver disease by academic pediatric hepatologists in Canada","volume":"3","author":"Kehar","year":"2022","journal-title":"JPGN Rep"},{"key":"R7-20250815","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease: screening, management, and transplant considerations","volume":"142","author":"Emamaullee","year":"2020","journal-title":"Circulation"},{"key":"R8-20250815","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2015.01.993","article-title":"Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes","volume":"34","author":"Wu","year":"2015","journal-title":"J Hear Lung Transplant"},{"key":"R9-20250815","doi-asserted-by":"crossref","first-page":"e004809","DOI":"10.1161\/JAHA.116.004809","article-title":"Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study","volume":"6","author":"Goldberg","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R10-20250815","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00246-020-02293-3","article-title":"Routine surveillance catheterization is useful in guiding management of stable Fontan patients","volume":"41","author":"Patel","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"R11-20250815","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtcvs.2021.12.028","article-title":"Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation","volume":"164","author":"Shin","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R12-20250815","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2016.07.006","article-title":"Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation","volume":"57","author":"Surrey","year":"2016","journal-title":"Hum Pathol"},{"key":"R13-20250815","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2024.09.005","article-title":"Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: the VALDIG-EASL FONLIVER cohort","volume":"82","author":"T\u00e9llez","year":"2025","journal-title":"J Hepatol"},{"key":"R14-20250815","doi-asserted-by":"crossref","first-page":"100362","DOI":"10.1016\/j.jhepr.2021.100362","article-title":"Non-invasive biomarkers of Fontan-associated liver disease","volume":"3","author":"Emamaullee","year":"2021","journal-title":"JHEP Rep"},{"key":"R15-20250815","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00246-016-1428-1","article-title":"MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores","volume":"37","author":"Evans","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"R16-20250815","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtcvs.2018.02.078","article-title":"Impact of hemodynamics and fluid energetics on liver fibrosis after Fontan operation","volume":"156","author":"Trusty","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-20250815","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/chd.12770","article-title":"Evaluation of Fontan liver disease: correlation of transjugular liver biopsy with magnetic resonance and hemodynamics","volume":"14","author":"Silva-Sepulveda","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"R18-20250815","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/hrt.2006.094516","article-title":"Hepatic changes in the failing Fontan circulation","volume":"93","author":"Kiesewetter","year":"2007","journal-title":"Heart"},{"key":"R19-20250815","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"R20-20250815","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"R21-20250815","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis: an update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R22-20250815","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/jcp.2007.052365","article-title":"Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study","volume":"61","author":"Kendall","year":"2008","journal-title":"J Clin Pathol"},{"key":"R23-20250815","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","author":"Bedossa","year":"1994","journal-title":"Hepatology"},{"key":"R24-20250815","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/modpathol.2014.79","article-title":"Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity","volume":"27","author":"Dai","year":"2014","journal-title":"Mod Pathol"},{"key":"R25-20250815","doi-asserted-by":"crossref","first-page":"182","DOI":"10.14740\/gr875e","article-title":"Histology and glutamine synthetase immunoreactivity in liver biopsies from patients with congestive heart failure","volume":"10","author":"Horvath","year":"2017","journal-title":"Gastroenterol Res"},{"key":"R26-20250815","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"R27-20250815","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Medica"},{"key":"R28-20250815","doi-asserted-by":"crossref","first-page":"e14120","DOI":"10.1111\/ctr.14120","article-title":"Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre\u2013combined heart and liver transplant and liver explant post-transplant","volume":"34","author":"Vaikunth","year":"2020","journal-title":"Clin Transplant"},{"key":"R29-20250815","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1111\/jocs.16880","article-title":"Hepatic fibrosis gender differences in extracardiac Fontan patients","volume":"37","author":"Evans","year":"2022","journal-title":"J Card Surg"},{"key":"R30-20250815","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/21501351231154216","article-title":"Hepatic fibrosis risk factors in extracardiac-Fontan patients: observations from a single center","volume":"14","author":"Evans","year":"2023","journal-title":"World J Pediatr Congenit Hear Surg"},{"key":"R31-20250815","first-page":"633","article-title":"Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes","volume":"9","author":"Guy","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"R32-20250815","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/apt.12974","article-title":"Review article: The management of cirrhosis in women","volume":"40","author":"Allen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-20250815","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.healun.2018.09.024","article-title":"Fontan-associated protein-losing enteropathy and post\u2013heart transplant outcomes: a multicenter study","volume":"38","author":"Schumacher","year":"2019","journal-title":"J Hear Lung Transplant"},{"key":"R34-20250815","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jtcvs.2020.07.107","article-title":"Protein-losing enteropathy and plastic bronchitis after the Fontan procedure","volume":"161","author":"Sharma","year":"2021","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T04:00:30Z","timestamp":1755230430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002418","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]}}}